ID   CLC4M_HUMAN             Reviewed;         399 AA.
AC   Q9H2X3; A6NKI4; A8K8B3; Q69F40; Q969M4; Q96QP3; Q96QP4; Q96QP5;
AC   Q96QP6; Q9BXS3; Q9H2Q9; Q9H8F0; Q9Y2A8;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-JUL-2015, entry version 144.
DE   RecName: Full=C-type lectin domain family 4 member M;
DE   AltName: Full=CD209 antigen-like protein 1;
DE   AltName: Full=DC-SIGN-related protein;
DE            Short=DC-SIGNR;
DE   AltName: Full=Dendritic cell-specific ICAM-3-grabbing non-integrin 2;
DE            Short=DC-SIGN2;
DE   AltName: Full=Liver/lymph node-specific ICAM-3-grabbing non-integrin;
DE            Short=L-SIGN;
DE   AltName: CD_antigen=CD299;
GN   Name=CLEC4M; Synonyms=CD209L, CD209L1, CD299;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9).
RC   TISSUE=Liver;
RX   PubMed=10072769; DOI=10.1016/S0378-1119(99)00004-9;
RA   Yokoyama-Kobayashi M., Yamaguchi T., Sekine S., Kato S.;
RT   "Selection of cDNAs encoding putative type II membrane proteins on the
RT   cell surface from a human full-length cDNA bank.";
RL   Gene 228:161-167(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=10975799; DOI=10.4049/jimmunol.165.6.2937;
RA   Soilleux E.J., Barten R., Trowsdale J.;
RT   "DC-SIGN, a related gene, DC-SIGNR, and CD23 form a cluster on
RT   19p13.";
RL   J. Immunol. 165:2937-2942(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4; 5; 6 AND 7), ALTERNATIVE
RP   SPLICING (ISOFORM 3), POLYMORPHISM, AND VARIANT GLN-164.
RX   PubMed=11337487; DOI=10.1074/jbc.M009807200;
RA   Mummidi S., Catano G., Lam L., Hoefle A., Telles V., Begum K.,
RA   Jimenez F., Ahuja S.S., Ahuja S.K.;
RT   "Extensive repertoire of membrane-bound and soluble dendritic cell-
RT   specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2
RT   isoforms. Inter-individual variation in expression of DC-SIGN
RT   transcripts.";
RL   J. Biol. Chem. 276:33196-33212(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), TISSUE SPECIFICITY, FUNCTION,
RP   INTERACTION WITH ICAM3 AND HIV-1 GP120, AND POLYMORPHISM.
RX   PubMed=11257134; DOI=10.1084/jem.193.6.671;
RA   Bashirova A.A., Geijtenbeek T.B.H., van Duijnhoven G.C.F.,
RA   van Vliet S.J., Eilering J.B.G., Martin M.P., Wu L., Martin T.D.,
RA   Viebig N., Knolle P.A., Kewalramani V.N., van Kooyk Y., Carrington M.;
RT   "A dendritic cell-specific intercellular adhesion molecule 3-grabbing
RT   nonintegrin (DC-SIGN)-related protein is highly expressed on human
RT   liver sinusoidal endothelial cells and promotes HIV-1 infection.";
RL   J. Exp. Med. 193:671-678(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASN-291.
RA   Bruen S., Bashirova A., Carrington M., KewalRamani V.;
RT   "L-SIGN interaction with HIV-1.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 8 AND 10).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY, INTERACTION WITH HIV-1 GP120, AND ROLE IN HIV-1
RP   INFECTION.
RX   PubMed=11226297; DOI=10.1073/pnas.051631398;
RA   Poehlmann S., Soilleux E.J., Baribaud F., Leslie G.J., Morris L.S.,
RA   Trowsdale J., Lee B., Coleman N., Doms R.W.;
RT   "DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds
RT   to human and simian immunodeficiency viruses and activates infection
RT   in trans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:2670-2675(2001).
RN   [10]
RP   SUBUNIT, AND LIGAND-BINDING.
RX   PubMed=11384997; DOI=10.1074/jbc.M104565200;
RA   Mitchell D.A., Fadden A.J., Drickamer K.;
RT   "A novel mechanism of carbohydrate recognition by the C-type lectins
RT   DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent
RT   ligands.";
RL   J. Biol. Chem. 276:28939-28945(2001).
RN   [11]
RP   INTERACTION WITH HIV-1 GP120; HIV-2 GP120; SIV GP120 AND EBOLA
RP   GLYCOPROTEINS.
RX   PubMed=12502850; DOI=10.1128/JVI.77.2.1337-1346.2003;
RA   Lin G., Simmons G., Poehlmann S., Baribaud F., Ni H., Leslie G.J.,
RA   Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W.;
RT   "Differential N-linked glycosylation of human immunodeficiency virus
RT   and Ebola virus envelope glycoproteins modulates interactions with DC-
RT   SIGN and DC-SIGNR.";
RL   J. Virol. 77:1337-1346(2003).
RN   [12]
RP   INTERACTION WITH HCV E2 GLYCOPROTEIN.
RX   PubMed=15371595; DOI=10.1073/pnas.0405695101;
RA   Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C.,
RA   Olson W.C., Gardner J.P., Dragic T.;
RT   "L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver
RT   cells by hepatitis C virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14067-14072(2004).
RN   [13]
RP   INTERACTION WITH SARS CORONAVIRUS S PROTEIN, AND TISSUE SPECIFICITY.
RX   PubMed=15496474; DOI=10.1073/pnas.0403812101;
RA   Jeffers S.A., Tusell S.M., Gillim-Ross L., Hemmila E.M.,
RA   Achenbach J.E., Babcock G.J., Thomas W.D. Jr., Thackray L.B.,
RA   Young M.D., Mason R.J., Ambrosino D.M., Wentworth D.E.,
RA   Demartini J.C., Holmes K.V.;
RT   "CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome
RT   coronavirus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15748-15753(2004).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 265-394 IN COMPLEX WITH
RP   GLCNAC(2)-MAN(3) PENTASACCHARIDE.
RX   PubMed=11739956; DOI=10.1126/science.1066371;
RA   Feinberg H., Mitchell D.A., Drickamer K., Weis W.I.;
RT   "Structural basis for selective recognition of oligosaccharides by DC-
RT   SIGN and DC-SIGNR.";
RL   Science 294:2163-2166(2001).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 216-399, AND DISULFIDE
RP   BONDS.
RX   PubMed=15509576; DOI=10.1074/jbc.M409925200;
RA   Feinberg H., Guo Y., Mitchell D.A., Drickamer K., Weis W.I.;
RT   "Extended neck regions stabilize tetramers of the receptors DC-SIGN
RT   and DC-SIGNR.";
RL   J. Biol. Chem. 280:1327-1335(2005).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.41 ANGSTROMS) OF 250-399, AND DISULFIDE
RP   BONDS.
RX   PubMed=15784257; DOI=10.1016/j.jmb.2005.01.063;
RA   Snyder G.A., Colonna M., Sun P.D.;
RT   "The structure of DC-SIGNR with a portion of its repeat domain lends
RT   insights to modeling of the receptor tetramer.";
RL   J. Mol. Biol. 347:979-989(2005).
CC   -!- FUNCTION: Probable pathogen-recognition receptor involved in
CC       peripheral immune surveillance in liver. May mediate the
CC       endocytosis of pathogens which are subsequently degraded in
CC       lysosomal compartments. Probably recognizes in a calcium-dependent
CC       manner high mannose N-linked oligosaccharides in a variety of
CC       pathogen antigens, including HIV-1 gp120, HIV-2 gp120, SIV gp120,
CC       ebolavirus glycoproteins, HCV E2, and human SARS coronavirus
CC       protein S. Is a receptor for ICAM3, probably by binding to
CC       mannose-like carbohydrates. Is presumably a coreceptor for the
CC       SARS coronavirus. {ECO:0000269|PubMed:11226297,
CC       ECO:0000269|PubMed:11257134}.
CC   -!- SUBUNIT: Homotetramer. Binds to many viral surface glycoproteins
CC       such as HIV-1 gp120, HIV-2 gp120, SIV gp120, ebolavirus
CC       glycoproteins, HCV E2, and human SARS coronavirus S protein.
CC       {ECO:0000269|PubMed:11384997, ECO:0000269|PubMed:11739956}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 6: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 7: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 10: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC         Comment=Additional isoforms seem to exist. Several splicing
CC         events may occur independently in a modular way. Deletion of the
CC         transmembrane domain encoding exon through alternative splicing
CC         produces soluble isoforms.;
CC       Name=1; Synonyms=mDC-SIGN2 type I;
CC         IsoId=Q9H2X3-1; Sequence=Displayed;
CC       Name=2; Synonyms=mDC-SIGN2 type III, mDC-SIGN2 type IV;
CC         IsoId=Q9H2X3-2; Sequence=VSP_010063, VSP_010064;
CC         Note=May be due to intron retention.;
CC       Name=3; Synonyms=mDC-SIGN2 type V;
CC         IsoId=Q9H2X3-3; Sequence=VSP_010065, VSP_010066;
CC       Name=4; Synonyms=mDC-SIGN2 type VI;
CC         IsoId=Q9H2X3-4; Sequence=VSP_010060, VSP_010062, VSP_010065,
CC                                  VSP_010066;
CC       Name=5; Synonyms=sDC-SIGN2 type I;
CC         IsoId=Q9H2X3-5; Sequence=VSP_010058, VSP_010061, VSP_010062;
CC       Name=6; Synonyms=sDC-SIGN2 type II;
CC         IsoId=Q9H2X3-6; Sequence=VSP_010058, VSP_010063, VSP_010064;
CC         Note=May be due to intron retention.;
CC       Name=7; Synonyms=sDC-SIGN2 type III;
CC         IsoId=Q9H2X3-7; Sequence=VSP_010058, VSP_010059;
CC       Name=8;
CC         IsoId=Q9H2X3-8; Sequence=VSP_010061;
CC         Note=Non-canonical intron-exon splice junction.;
CC       Name=9;
CC         IsoId=Q9H2X3-9; Sequence=VSP_010056, VSP_010065, VSP_010066;
CC       Name=10;
CC         IsoId=Q9H2X3-10; Sequence=VSP_010056, VSP_010057, VSP_010063,
CC                                   VSP_010064;
CC         Note=May be due to intron retention.;
CC   -!- TISSUE SPECIFICITY: Predominantly highly expressed in liver
CC       sinusoidal endothelial cells and in lymph node. Found in placental
CC       endothelium but not in macrophages. Expressed in type II alveolar
CC       cells and lung endothelial cells. {ECO:0000269|PubMed:11226297,
CC       ECO:0000269|PubMed:11257134, ECO:0000269|PubMed:15496474}.
CC   -!- DOMAIN: The tandem repeat domain, also called neck domain,
CC       mediates oligomerization.
CC   -!- POLYMORPHISM: The number of repeats in the tandem repeat domain is
CC       shown to vary between 3 and 9 per allele thus contributing to a
CC       further variability in addition to alternative splicing. The shown
CC       7 repeat-containing form has been shown to be the most frequent
CC       one (53.9%) in a study with 350 Caucasian individuals.
CC   -!- MISCELLANEOUS: In vitro, is a receptor for HIV-1 and transmits
CC       HIV-1 to permissive T-cells.
CC   -!- SIMILARITY: Contains 1 C-type lectin domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00040}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAR04559.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=DC-SIGNR;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_00122";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB015629; BAA76496.1; -; mRNA.
DR   EMBL; AF245219; AAG13848.2; -; mRNA.
DR   EMBL; AF209481; AAG13815.2; -; Genomic_DNA.
DR   EMBL; AF209480; AAG13815.2; JOINED; Genomic_DNA.
DR   EMBL; AY042234; AAK91859.1; -; mRNA.
DR   EMBL; AY042235; AAK91860.1; -; mRNA.
DR   EMBL; AY042236; AAK91861.1; -; mRNA.
DR   EMBL; AY042237; AAK91862.1; -; mRNA.
DR   EMBL; AY042238; AAK91863.1; -; mRNA.
DR   EMBL; AY042239; AAK91864.1; -; mRNA.
DR   EMBL; AY042240; AAK91865.1; -; mRNA.
DR   EMBL; AF290887; AAK20998.1; -; mRNA.
DR   EMBL; AY343913; AAR04559.1; ALT_SEQ; mRNA.
DR   EMBL; AK023750; BAB14667.1; -; mRNA.
DR   EMBL; AK292278; BAF84967.1; -; mRNA.
DR   EMBL; AC008812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC038851; AAH38851.1; -; mRNA.
DR   CCDS; CCDS12187.1; -. [Q9H2X3-1]
DR   CCDS; CCDS59346.1; -. [Q9H2X3-4]
DR   CCDS; CCDS59347.1; -. [Q9H2X3-7]
DR   CCDS; CCDS59348.1; -. [Q9H2X3-9]
DR   RefSeq; NP_001138377.1; NM_001144905.1.
DR   RefSeq; NP_001138378.1; NM_001144906.1. [Q9H2X3-7]
DR   RefSeq; NP_001138379.1; NM_001144907.1. [Q9H2X3-5]
DR   RefSeq; NP_001138380.1; NM_001144908.1. [Q9H2X3-4]
DR   RefSeq; NP_001138381.1; NM_001144909.1.
DR   RefSeq; NP_001138382.1; NM_001144910.1. [Q9H2X3-8]
DR   RefSeq; NP_001138383.1; NM_001144911.1. [Q9H2X3-9]
DR   RefSeq; NP_055072.3; NM_014257.4. [Q9H2X3-1]
DR   RefSeq; XP_006722678.1; XM_006722615.1. [Q9H2X3-3]
DR   UniGene; Hs.421437; -.
DR   PDB; 1K9J; X-ray; 1.90 A; A/B=262-399.
DR   PDB; 1SL6; X-ray; 2.25 A; A/B/C/D/E/F=216-399.
DR   PDB; 1XAR; X-ray; 2.25 A; A/B=216-399.
DR   PDB; 1XPH; X-ray; 1.41 A; A=250-399.
DR   PDB; 1Z0Y; Model; -; A/B/C/D=85-399.
DR   PDB; 3JQH; X-ray; 2.20 A; A=101-264.
DR   PDBsum; 1K9J; -.
DR   PDBsum; 1SL6; -.
DR   PDBsum; 1XAR; -.
DR   PDBsum; 1XPH; -.
DR   PDBsum; 1Z0Y; -.
DR   PDBsum; 3JQH; -.
DR   ProteinModelPortal; Q9H2X3; -.
DR   SMR; Q9H2X3; 219-398.
DR   BioGrid; 115615; 7.
DR   IntAct; Q9H2X3; 2.
DR   MINT; MINT-1489134; -.
DR   STRING; 9606.ENSP00000316228; -.
DR   ChEMBL; CHEMBL2176858; -.
DR   PhosphoSite; Q9H2X3; -.
DR   BioMuta; CLEC4M; -.
DR   DMDM; 46395990; -.
DR   PaxDb; Q9H2X3; -.
DR   PRIDE; Q9H2X3; -.
DR   DNASU; 10332; -.
DR   Ensembl; ENST00000248228; ENSP00000248228; ENSG00000104938. [Q9H2X3-8]
DR   Ensembl; ENST00000327325; ENSP00000316228; ENSG00000104938.
DR   Ensembl; ENST00000359059; ENSP00000351954; ENSG00000104938. [Q9H2X3-5]
DR   Ensembl; ENST00000595496; ENSP00000470132; ENSG00000104938. [Q9H2X3-7]
DR   Ensembl; ENST00000596363; ENSP00000471125; ENSG00000104938. [Q9H2X3-9]
DR   Ensembl; ENST00000597522; ENSP00000471132; ENSG00000104938. [Q9H2X3-4]
DR   GeneID; 10332; -.
DR   UCSC; uc002mhy.2; human. [Q9H2X3-10]
DR   UCSC; uc002mhz.3; human. [Q9H2X3-4]
DR   UCSC; uc002mia.3; human. [Q9H2X3-7]
DR   UCSC; uc002mic.3; human. [Q9H2X3-9]
DR   UCSC; uc002mih.3; human. [Q9H2X3-8]
DR   UCSC; uc010xjw.2; human. [Q9H2X3-5]
DR   CTD; 10332; -.
DR   GeneCards; GC19P007828; -.
DR   HGNC; HGNC:13523; CLEC4M.
DR   HPA; CAB033689; -.
DR   HPA; CAB033691; -.
DR   HPA; HPA042661; -.
DR   MIM; 605872; gene.
DR   neXtProt; NX_Q9H2X3; -.
DR   PharmGKB; PA26200; -.
DR   eggNOG; NOG314197; -.
DR   GeneTree; ENSGT00760000118924; -.
DR   HOVERGEN; HBG050992; -.
DR   InParanoid; Q9H2X3; -.
DR   OMA; DNYWICK; -.
DR   OrthoDB; EOG7DFXC9; -.
DR   PhylomeDB; Q9H2X3; -.
DR   TreeFam; TF333341; -.
DR   EvolutionaryTrace; Q9H2X3; -.
DR   GeneWiki; CLEC4M; -.
DR   GenomeRNAi; 10332; -.
DR   NextBio; 39173; -.
DR   PRO; PR:Q9H2X3; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; Q9H2X3; -.
DR   ExpressionAtlas; Q9H2X3; baseline and differential.
DR   Genevisible; Q9H2X3; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:AgBase.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0030369; F:ICAM-3 receptor activity; NAS:UniProtKB.
DR   GO; GO:0005537; F:mannose binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; NAS:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; NAS:UniProtKB.
DR   GO; GO:0046790; F:virion binding; TAS:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IDA:CACAO.
DR   GO; GO:0019882; P:antigen processing and presentation; NAS:UniProtKB.
DR   GO; GO:0009988; P:cell-cell recognition; TAS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; NAS:UniProtKB.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0019048; P:modulation by virus of host morphology or physiology; TAS:UniProtKB.
DR   GO; GO:0046968; P:peptide antigen transport; NAS:UniProtKB.
DR   GO; GO:0030193; P:regulation of blood coagulation; IMP:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0046718; P:viral entry into host cell; IDA:GOC.
DR   GO; GO:0019079; P:viral genome replication; NAS:UniProtKB.
DR   GO; GO:0019062; P:virion attachment to host cell; TAS:UniProtKB.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Calcium;
KW   Cell membrane; Complete proteome; Disulfide bond; Endocytosis;
KW   Glycoprotein; Host-virus interaction; Immunity; Innate immunity;
KW   Lectin; Mannose-binding; Membrane; Metal-binding; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Secreted; Signal-anchor;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    399       C-type lectin domain family 4 member M.
FT                                /FTId=PRO_0000046626.
FT   TOPO_DOM      1     49       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     50     70       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000305}.
FT   TOPO_DOM     71    399       Extracellular. {ECO:0000305}.
FT   REPEAT      108    130       1.
FT   REPEAT      131    153       2.
FT   REPEAT      154    176       3.
FT   REPEAT      177    199       4.
FT   REPEAT      200    222       5.
FT   REPEAT      223    245       6.
FT   REPEAT      246    268       7.
FT   DOMAIN      274    390       C-type lectin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00040}.
FT   REGION      108    269       7 X approximate tandem repeats.
FT   MOTIF        14     15       Endocytosis signal. {ECO:0000250}.
FT   METAL       359    359       Calcium.
FT   METAL       361    361       Calcium.
FT   METAL       363    363       Calcium; via carbonyl oxygen.
FT   METAL       366    366       Calcium.
FT   METAL       377    377       Calcium.
FT   METAL       378    378       Calcium.
FT   CARBOHYD     92     92       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    361    361       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    265    395
FT   DISULFID    268    279
FT   DISULFID    296    389
FT   DISULFID    368    381
FT   VAR_SEQ      16     43       Missing (in isoform 9 and isoform 10).
FT                                {ECO:0000303|PubMed:10072769,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010056.
FT   VAR_SEQ      44     71       Missing (in isoform 10).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010057.
FT   VAR_SEQ      44     71       GCLGHGALVLQLLSFMLLAGVLVAILVQ -> VPFLLGP
FT                                (in isoform 5, isoform 6 and isoform 7).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010058.
FT   VAR_SEQ     147    261       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010059.
FT   VAR_SEQ     170    238       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010060.
FT   VAR_SEQ     177    199       Missing (in isoform 5 and isoform 8).
FT                                {ECO:0000303|PubMed:11257134,
FT                                ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010061.
FT   VAR_SEQ     239    261       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010062.
FT   VAR_SEQ     262    272       ERLCRHCPKDW -> GEFLHIKGPWA (in isoform 2,
FT                                isoform 6 and isoform 10).
FT                                {ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010063.
FT   VAR_SEQ     273    399       Missing (in isoform 2, isoform 6 and
FT                                isoform 10).
FT                                {ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010064.
FT   VAR_SEQ     313    324       NFLQLQTSRSNR -> LPAVLEQWRTQQ (in isoform
FT                                3, isoform 4 and isoform 9).
FT                                {ECO:0000303|PubMed:10072769,
FT                                ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010065.
FT   VAR_SEQ     325    399       Missing (in isoform 3, isoform 4 and
FT                                isoform 9). {ECO:0000303|PubMed:10072769,
FT                                ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010066.
FT   VARIANT     164    164       R -> Q (in dbSNP:rs11465376).
FT                                {ECO:0000269|PubMed:11337487}.
FT                                /FTId=VAR_050107.
FT   VARIANT     205    205       Y -> C (in dbSNP:rs479448).
FT                                /FTId=VAR_050108.
FT   VARIANT     251    251       Y -> C (in dbSNP:rs479448).
FT                                /FTId=VAR_050109.
FT   VARIANT     291    291       D -> N (in dbSNP:rs2277998).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_021957.
FT   CONFLICT     99     99       A -> T (in Ref. 5; BAB14667).
FT                                {ECO:0000305}.
FT   HELIX       220    232       {ECO:0000244|PDB:1SL6}.
FT   HELIX       262    264       {ECO:0000244|PDB:1XPH}.
FT   STRAND      273    275       {ECO:0000244|PDB:1XPH}.
FT   STRAND      278    282       {ECO:0000244|PDB:1XPH}.
FT   HELIX       289    298       {ECO:0000244|PDB:1XPH}.
FT   HELIX       309    322       {ECO:0000244|PDB:1XPH}.
FT   STRAND      326    331       {ECO:0000244|PDB:1XPH}.
FT   STRAND      333    335       {ECO:0000244|PDB:1K9J}.
FT   HELIX       349    354       {ECO:0000244|PDB:1XPH}.
FT   STRAND      362    365       {ECO:0000244|PDB:1XAR}.
FT   STRAND      368    372       {ECO:0000244|PDB:1XPH}.
FT   STRAND      375    379       {ECO:0000244|PDB:1XPH}.
FT   STRAND      385    392       {ECO:0000244|PDB:1XPH}.
SQ   SEQUENCE   399 AA;  45350 MW;  0FADC99F72AEA593 CRC64;
     MSDSKEPRVQ QLGLLEEDPT TSGIRLFPRD FQFQQIHGHK SSTGCLGHGA LVLQLLSFML
     LAGVLVAILV QVSKVPSSLS QEQSEQDAIY QNLTQLKAAV GELSEKSKLQ EIYQELTQLK
     AAVGELPEKS KLQEIYQELT RLKAAVGELP EKSKLQEIYQ ELTRLKAAVG ELPEKSKLQE
     IYQELTRLKA AVGELPEKSK LQEIYQELTE LKAAVGELPE KSKLQEIYQE LTQLKAAVGE
     LPDQSKQQQI YQELTDLKTA FERLCRHCPK DWTFFQGNCY FMSNSQRNWH DSVTACQEVR
     AQLVVIKTAE EQNFLQLQTS RSNRFSWMGL SDLNQEGTWQ WVDGSPLSPS FQRYWNSGEP
     NNSGNEDCAE FSGSGWNDNR CDVDNYWICK KPAACFRDE
//
